ADME Toxicology Testing Market Size, Share, Trends, Growth Outlook

ADME Toxicology Testing Market is estimated to increase at a growth rate of 11.1% CAGR over the forecast period from 2024 to 2030.

The ADME Toxicology Testing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Others), By Method (Cellular Assay, Biochemical Assay, In-Silica, Ex-vivo).

An Introduction to ADME Toxicology Testing Market in 2024

The ADME Toxicology Testing Market in 2024 is experiencing significant growth, driven by the increasing demand for predictive toxicology assays and safety pharmacology studies in drug discovery and development pipelines. Absorption, Distribution, Metabolism, and Excretion (ADME) testing plays a critical role in assessing the pharmacokinetic properties, metabolic fate, and toxicological profiles of drug candidates, enabling informed decision-making and regulatory submissions in pharmaceutical research and preclinical studies. With advancements in in vitro assays, high-throughput screening platforms, and computational modeling techniques, the market offers a variety of ADME toxicology testing services, including cytochrome P450 inhibition assays, drug-drug interaction studies, and genotoxicity assessments, tailored to specific compound characteristics and regulatory requirements. Moreover, the integration of organ-on-a-chip technology, 3D tissue models, and omics profiling further enhances the predictive accuracy, mechanistic insights, and translational relevance of ADME toxicology testing, driving market expansion and enabling safer and more efficacious drug development pipelines.

ADME Toxicology Testing Market Trend: Growing Emphasis on In Vitro ADME Toxicology Testing

A prominent trend in the ADME Toxicology Testing market is the growing emphasis on in vitro testing methods for assessing absorption, distribution, metabolism, and excretion (ADME) properties of pharmaceutical compounds. Traditional in vivo animal studies for evaluating drug safety and toxicity are resource-intensive, time-consuming, and often ethically challenging. As a result, there is a shift towards the adoption of in vitro ADME toxicology testing approaches, leveraging cell-based assays, organ-on-a-chip models, and high-throughput screening platforms. These in vitro methods offer greater predictive accuracy, reproducibility, and scalability compared to traditional animal models, enabling pharmaceutical companies to streamline drug development processes, reduce costs, and adhere to ethical considerations related to animal welfare.

ADME Toxicology Testing Market Driver: Rising Demand for Safer and More Effective Pharmaceuticals

The primary driver fueling the ADME Toxicology Testing market is the rising demand for safer and more effective pharmaceuticals in the healthcare industry. Drug development pipelines are increasingly focused on the discovery and development of novel therapeutics with improved efficacy, reduced toxicity, and enhanced pharmacokinetic properties. Comprehensive ADME toxicology testing plays a crucial role in identifying potential safety concerns, optimizing drug candidates, and mitigating the risk of adverse drug reactions (ADRs) during clinical trials and post-market surveillance. Regulatory agencies worldwide require extensive preclinical ADME toxicology data to assess the safety profiles of pharmaceutical compounds and ensure patient safety. Consequently, pharmaceutical companies are investing in advanced ADME toxicology testing platforms and technologies to accelerate drug discovery and development timelines while maintaining compliance with regulatory requirements.

ADME Toxicology Testing Market Opportunity: Integration of Advanced Technologies for Predictive Toxicology Assessment

An opportunity in the ADME Toxicology Testing market lies in the integration of advanced technologies and computational modeling approaches for predictive toxicology assessment. Traditional ADME toxicology assays often focus on assessing individual endpoints or organ systems, limiting their ability to predict complex drug interactions, multi-organ toxicity, and idiosyncratic adverse effects. By leveraging emerging technologies such as artificial intelligence (AI), machine learning (ML), and quantitative structure-activity relationship (QSAR) modeling, pharmaceutical companies can enhance the predictive capabilities of ADME toxicology testing platforms. Integrating multi-omics data, bioinformatics tools, and systems biology approaches enables comprehensive toxicity profiling, identification of biomarkers, and elucidation of underlying mechanisms of drug-induced toxicity. By leveraging predictive toxicology assessments early in the drug discovery process, pharmaceutical companies can prioritize safer drug candidates, reduce late-stage attrition rates, and accelerate the development of innovative therapies with improved clinical outcomes. Collaborative partnerships between pharmaceutical companies, contract research organizations (CROs), academic institutions, and technology providers are essential to advance the adoption of advanced technologies in ADME toxicology testing and drive innovation in drug discovery and development.

ADME Toxicology Testing Market Segmentation

By Technology
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application
Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Others
By Method
Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

ADME Toxicology Testing Market Companies

Agilent Technologies Inc
Beckman Coulter Inc
Catalent Inc
Charles River Laboratories
Curia Global Inc
Dassault Systèmes
Eurofins Scientific
GE HealthCare
IQVIA Inc
Labcorp Drug Development
Miltenyi Biotec
Promega Corp
Thermo Fisher Scientific Inc

 

 

Reasons to Buy the ADME Toxicology Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the ADME Toxicology Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the ADME Toxicology Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 ADME Toxicology Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global ADME Toxicology Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 ADME Toxicology Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 ADME Toxicology Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 ADME Toxicology Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 ADME Toxicology Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of ADME Toxicology Testing Market Industry
4.2 Key Market Trends in ADME Toxicology Testing Market Industry
4.3 Potential Opportunities in ADME Toxicology Testing Market Industry
4.4 Key Challenges in ADME Toxicology Testing Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global ADME Toxicology Testing Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global ADME Toxicology Testing Market Outlook By Segments
7.1 ADME Toxicology Testing Market Outlook by Segments
By Technology
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application
Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Others
By Method
Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo

8 North America ADME Toxicology Testing Market Analysis And Outlook To 2030
8.1 Introduction to North America ADME Toxicology Testing Markets in 2024
8.2 North America ADME Toxicology Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America ADME Toxicology Testing Market size Outlook by Segments, 2021-2030
By Technology
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application
Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Others
By Method
Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo

9 Europe ADME Toxicology Testing Market Analysis And Outlook To 2030
9.1 Introduction to Europe ADME Toxicology Testing Markets in 2024
9.2 Europe ADME Toxicology Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe ADME Toxicology Testing Market Size Outlook By Segments, 2021-2030
By Technology
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application
Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Others
By Method
Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo

10 Asia Pacific ADME Toxicology Testing Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific ADME Toxicology Testing Markets in 2024
10.2 Asia Pacific ADME Toxicology Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific ADME Toxicology Testing Market size Outlook by Segments, 2021-2030
By Technology
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application
Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Others
By Method
Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo

11 South America ADME Toxicology Testing Market Analysis And Outlook To 2030
11.1 Introduction to South America ADME Toxicology Testing Markets in 2024
11.2 South America ADME Toxicology Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America ADME Toxicology Testing Market size Outlook by Segments, 2021-2030
By Technology
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application
Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Others
By Method
Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo

12 Middle East And Africa ADME Toxicology Testing Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa ADME Toxicology Testing Markets in 2024
12.2 Middle East and Africa ADME Toxicology Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa ADME Toxicology Testing Market size Outlook by Segments, 2021-2030
By Technology
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application
Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Others
By Method
Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
Beckman Coulter Inc
Catalent Inc
Charles River Laboratories
Curia Global Inc
Dassault Systèmes
Eurofins Scientific
GE HealthCare
IQVIA Inc
Labcorp Drug Development
Miltenyi Biotec
Promega Corp
Thermo Fisher Scientific Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Technology
Cell Culture
High Throughput
Molecular Imaging
OMICS Technology
By Application
Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Others
By Method
Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo